Scholar Rock Holding is a biopharmaceutical company committed to discovering and developing innovative medicines that target the transforming growth factor beta (TGFβ) superfamily of proteins to treat serious diseases with high unmet medical need.

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>The Senior Director, Patient Marketing (US) will play a critical leadership role in the preparation for and execution of Scholar Rock’s first U.S. commercial launch. This role will be accountable for developing and driving the U.S. patient and caregiver marketing strategy and tactical execution for apitegromab, the first and only muscle-targeted therapy for spinal muscular atrophy (SMA).</div><div><br></div><div>This individual will own the U.S. patient brand strategy from launch through commercialization, ensuring a deeply patient-centric approach across education, engagement, and community presence. The role will lead the development of integrated, compliant, multi-channel patient programs designed to support awareness, understanding, and empowerment throughout the patient journey.</div><div><br></div><div>As a senior leader on the U.S. Marketing Team, this role will work closely with Patient Services, Medical Affairs, Advocacy, Market Access, Legal, Regulatory, and Compliance to ensure a cohesive, high-quality experience for patients and caregivers. This is a high-impact, high-visibility role with the opportunity to shape how Scholar Rock engages with the SMA community as it brings its first therapy to patients.</div><div><br></div><div><br></div><div><br></div><div><b style="font-size: 18px">Position Responsibilities:</b></div>

Senior Director, Patient Marketing (US)

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div><span style="font-size: 10.5pt;">The Associate Director, Field Reimbursement will support patients and caregivers by enhancing access to a potentially novel treatment option for individuals living with Spinal Muscular Atrophy (SMA). Acting as a trusted partner to healthcare providers and institutions (including C-suite, hospital administration and Pharmacy Directors), you will address reimbursement and access barriers through strategic account management, resource utilization and education. </span></div><div><span style="font-size: 10.5pt;">&nbsp;</span></div><div><span style="font-size: 10.5pt;">This role offers a unique opportunity to make a significant impact on the lives of individuals living with a rare neuromuscular disease by ensuring access, support, and continuity of care throughout their treatment journey. The Associate Director, Field Reimbursement will be a critical member of the broader Patient Access and Experience Team.</span></div>

Associate Director, Field Reimbursement (Great Lakes)

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>The Rx Onboarding and Care Coordinator (ROCC) is a patient journey expert focused on delivering personalized education and comprehensive care coordination to support patients and families throughout their spinal muscular atrophy (SMA) treatment journey. Acting as a trusted patient advocate, the ROCC serves as the central point of contact, bridging communication between patients, caregivers, healthcare teams, and advocacy groups to support appropriate patients at all stages of the treatment journey. This role focuses on the patient experience through uncovering individual needs and delivering customized tools and resources to address them. The ROCC will be the connection to resources that address access, affordability, and logistical challenges and will work cross-functionally to identify and compliantly remove non-clinical barriers. With an emphasis on empowering patients and caregivers, the ROCC will lead with empathy to provide tailored education and connections to practical solutions and tools that effectively address non-clinical barriers to access and improve patient experience.</div><div>&nbsp;</div><div>The ROCC role offers a unique opportunity to make a significant impact on the lives of individuals living with a rare neuromuscular disease by ensuring access, support, and continuity of care throughout their treatment journey. The ROCC will be a critical member of the broader Patient Access and Experience Team.</div>

Rx Onboarding and Care Coordinator, Philadelphia

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>As US Medical Director, this person will be a strategic thought partner providing expert medical leadership and contributing to the development and execution of the US medical strategy.&nbsp; This person will lead content development, KOL education programs, and support our cross-functional field teams for the US. As a key member of the US Medical team, reporting to VP of US Medical Affairs, this person will be accountable for advancing SRK’s scientific leadership in Rare Neuromuscular Diseases including SMA and other pipeline indications. This person will thrive in this role if he/she is a self-starter and a highly collaborative individual who cares to have impact on patients in the rare disease space.</div>

US Medical Director Neuromuscular

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div><span style="font-size: 12pt;">Scholar Rock&nbsp;is seeking a&nbsp;Director of Toxicology&nbsp;that will be responsible for the&nbsp;creation and execution of the nonclinical safety strategy.&nbsp;&nbsp;The successful candidate&nbsp;will be responsible for&nbsp;operational&nbsp;oversight&nbsp;as well as the interpretation and communication of&nbsp;toxicology&nbsp;data&nbsp;to support&nbsp;the&nbsp;advancement&nbsp;of Scholar Rock’s discovery and development&nbsp;portfolio.&nbsp;&nbsp;&nbsp;Reporting to the Vice President, Head of Preclinical Sciences, this&nbsp;individual&nbsp;will design and implement fit-for-purpose&nbsp;toxicology&nbsp;approaches&nbsp;(including the incorporation of NAMs), oversee&nbsp;studies conducted at CROs, interpret and communicate safety&nbsp;data, and serve as a key contributor to&nbsp;program strategy and&nbsp;regulatory submissions. This individual will be a member of the&nbsp;Research&nbsp;Leadership&nbsp;Team.&nbsp;</span></div>

Director of Toxicology

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div><span style="font-size: 11pt;">As Country Medical Director, this person will be a strategic thought partner providing expert medical leadership and contributing to the development and execution of the Country launch strategy.&nbsp; This person will lead content development, KOL education programs, and support our cross-functional teams in Germany. As a key member of the European Medical team, reporting to EU Head of Medical Affairs, this person will be accountable for advancing Scholar Rock’s scientific leadership in Rare Neuromuscular Diseases including SMA and other pipeline indications. This person will thrive in this role if he/she is a self-starter and a highly collaborative individual who cares to have impact on patients in the rare disease space.</span></div><div><br></div><div>Scholar Rock is in the process of building its team in Germany, and the location of the future German headquarter is currently under evaluation, with Munich and Frankfurt being the leading options.</div>

Country Medical Director, Germany

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>The Field Medical Advisor will represent the real time voice of KOL/HCP input related to product development opportunities and scientific exchange on pipeline and commercial products, including conducting clinical presentations to payers.&nbsp; The ideal candidate will be a strong leader with a proven ability to leverage their high scientific acumen to engage and educate on scientifically complex concepts and products. The preferred candidate will also have a proven strategic and innovative style combined with a flexible, hands-on nature that works with a high sense of urgency.</div>

Field Medical Advisor, North

Field Medical Advisor, South

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>The Regional Business Leader is responsible for driving commercial success, shaping regional launch success, and developing strong relationships with key stakeholders within the rare disease ecosystem—with a specific and initial focus on Spinal Muscular Atrophy (SMA). The role combines high engagement field presence and strategic account management, ensuring timely and appropriate access to innovative therapies for patients living with SMA.</div><div><br></div>

Regional Business Leader, East

Regional Business Leader, North

Regional Business Leader, South/Southwest

Regional Business Leader, West/Central West

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div><span style="font-size: medium;">Scholar Rock is seeking an outstanding individual to play an important role in the discovery and development of novel biotherapeutics for neuromuscular disorders. The successful candidate will join the Discovery Biology group to run cell-based assays and perform ex vivo tissue analyses to characterize novel antibody drug candidates. Through this position the candidate will be able to contribute to and learn about the drug discovery process.</span></div>

Co-op, Discovery Biology, Cell-Based Assays

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>The Director, KOL Engagement (US) will play a critical role in building and sustaining deep, trusted relationships with key opinion leaders (KOLs) in advance of and through Scholar Rock’s first U.S. commercial launch. This role will be accountable for developing and executing the U.S. KOL engagement strategy and plan for apitegromab, ensuring meaningful, compliant interactions that generate insight, foster advocacy, and support launch readiness.</div><div><br></div><div>This individual will work cross-functionally with Medical Affairs, Marketing, Sales, Market Access, and Field teams to design and deliver high-impact KOL engagement initiatives, including peer-to-peer programs, advisory boards, congress engagement, and innovative engagement formats. The role will serve as a connective tissue across functions, ensuring alignment, coordination, and consistency in how Scholar Rock engages with the external expert community.</div><div><br></div><div>This is a high-impact, highly collaborative role with the opportunity to shape Scholar Rock’s external scientific and clinical relationships as the company enters commercialization.</div><div><br></div><div><br></div><div><b style="font-size: 18px">Position Responsibilities:</b></div>

Director, KOL Engagement (US)

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>The Senior Director, HCP Marketing (US) will play a critical leadership role in the preparation for and execution of Scholar Rock’s first U.S. commercial launch. This role will be accountable for developing and driving the U.S. healthcare professional (HCP) marketing strategy and tactical execution for apitegromab, the first and only muscle-targeted therapy for spinal muscular atrophy (SMA).</div><div>This individual will own the U.S. HCP brand strategy from launch through commercialization, ensuring clear differentiation, compelling scientific communication, and flawless execution across channels. The role will work closely with U.S. commercial, medical, market access, and patient services teams to deliver an integrated launch.</div><div><br></div><div>In addition to U.S. leadership responsibilities, this role will provide limited ex-U.S. support (~10%), focused on strategic alignment, communication, and knowledge sharing with regional and local teams to ensure consistency of core HCP strategy while respecting local needs.</div><div>&nbsp;</div><div>This is a high-impact, high-visibility role within a fast-growing organization and an opportunity to shape the commercial foundation of Scholar Rock’s first marketed product.</div><div><br></div><div><br></div><div><b style="font-size: 18px;">Position Responsibilities:</b></div>

Senior Director, HCP Marketing (US)

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div><span style="font-size: 11pt;">Reporting to the SVP, Finance, the Senior Accounting Manager will manage the monthly close process and help ensure closing timelines are maintained.&nbsp; The Senior Accounting Manager will serve as the primary coordinator for the Concur platform and the corporate credit card program, as well as oversee the Accounts Payable function.&nbsp; The Accounting Manager will incorporate/maintain processes to ensure compliance with SOX, as well as external reporting requirements. The ideal candidate for this position will excel in a rapidly evolving environment.&nbsp; The candidate should be able to analyze processes and propose and execute necessary process improvements. The candidate should be able to maintain a positive attitude while staying organized in a fast-paced, growth environment.&nbsp; This role will require strong organization, clear communication, attention to detail and a great sense of teamwork and will help to build a critical function at a growing and evolving, multi-product candidate biotechnology company.</span></div>

Senior Accounting Manager

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Scholar Rock is seeking a highly experienced and technically strong Senior Director of Drug Product External Manufacturing to lead drug product external manufacturing for our portfolio of biologics, including monoclonal antibodies, fusion proteins, and bispecifics. In this role you will lead and oversee all drug product manufacturing operations managed through external contract manufacturing organizations (CMOs). This role is critical in ensuring the seamless production, quality, and delivery of clinical and commercial products, aligning with company goals and regulatory standards. The ideal candidate will possess deep expertise in biopharmaceutical manufacturing, strategic leadership, and a strong ability to manage complex global operations.</div>

Senior Director, Drug Product External Manufacturing

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Scholar Rock is transitioning from a clinical-stage organization to a commercial-stage biotech, and IT Service Delivery sits at the center of that transformation. We are looking for a dynamic, hands-on leader to stabilize and elevate our IT service desk while laying the foundation for a modern, scalable, and customer-centric service model. This role offers significant visibility, ownership, and influence. You will shape how IT is experienced across the company—supporting a diverse workforce of onsite, hybrid, and remote users—while partnering closely with internal teams and external managed service providers.</div><div><br></div><div>As Associate Director/ Director of IT Service Delivery, you will:</div><div> • Own the end-to-end employee IT support experience</div><div> • Lead internal support staff and manage external managed service providers</div><div> • Establish operational rigor, service reliability, and stakeholder trust</div><div> • Drive continuous improvement and long-term transformation of IT service delivery</div><div><br></div><div>You will stabilize what exists today, then evolve it into a best-in-class service organization aligned with a regulated, fast-growing biotech environment.</div><div><br></div>

Associate Director, IT Service Delivery

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div><span style="font-size: 11pt;">Scholar Rock is seeking an experienced and motivated Director of Quality Systems and GxP Compliance. Reporting to the Head of Quality, this position will oversee all aspects of quality systems and regulatory compliance across commercial, clinical, and development activities. The Director will lead the implementation and maintenance of an effective Quality Management System (QMS) to ensure compliance with global regulatory requirements.</span></div>

Senior Director, Global Quality Systems and Compliance

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div>

Director, Upstream MSAT & Process Development

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Scholar Rock is seeking an experienced and motivated Senior Director of Global Quality Control. Reporting to the Head of Global Quality, this position is the senior QC leader responsible for establishing and maintaining a phase-appropriate, scalable, and inspection-ready global QC strategy for a fully outsourced development and manufacturing network. This role provides strategic and technical leadership for Quality Control activities executed through external contract laboratories, CMOs, and other testing partners supporting drug substance, drug product, raw materials, in-process, release, and stability programs.</div>

Sr. Director, Global Quality Control

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Scholar Rock is seeking an experienced and motivated Senior Director of US Quality Assurance. Reporting to the Head of Global Quality, this position provides strategic and operational leadership for US Quality Assurance with a strong focus on external partner governance, quality risk management, and scalable quality infrastructure to support development through commercialization.</div>

Sr. Director, US Quality Assurance

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>The Director of Demand Planning and S&amp;OP is responsible for the strategic planning, development, and management of the company's processes to ensure accurate planning models for commercial, clinical and early access programs for global markets.&nbsp;The role will have responsibility and accountability for the Sales &amp; Operational Planning process.The position requires strong leadership, problem-solving, and analytical skills to optimize operational efficiency and ensure products are reliably and compliantly supplied across US, EU, Japan and Rest of World. In addition, the candidate will collaborate with and support colleagues in various other supply chain activities at times to ensure continuity of supply to patients.</div><div><br></div><div><br></div><div><b><span style="font-size: 18px;">Position Responsibilities</span></b></div>

Director, Demand Planning and S&OP

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div><span style="font-size: 11pt;">The Medical Director/Senior Director, reporting to the SVP, Clinical Research, will be a member of the late-stage development team, accountable for driving clinical development activities for product candidates from Proof-of-Concept through marketing approval and lifecycle management. The successful candidate will be responsible for providing medical leadership for clinical development activities for apitegromab as well as other product candidates entering late-stage development, in alignment with corporate strategy. This position requires a highly motivated physician scientist with hands-on expertise in advancing late-stage product candidates to deliver life-changing medicines.</span></div>

Medical Director/Sr. Director, Clinical Research

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Scholar Rock is seeking a Director of Program Management to serve as the primary operational partner for the Myostatin Core Team. As the organization advances apitegromab through late-stage development and into commercialization, this role ensures the Core Team operates with precision, velocity, and alignment.</div><div><br></div><div>This position is designed for a high-accountability operator who partners seamlessly with the Program Leader. While the Program Leader focuses on executive alignment and organizational strategy ("managing up and out"), the Program Manager focuses on internal team efficacy and execution ("managing in and down"). We require a leader with the professional maturity to navigate the complexities of Lifecycle Management and the humility to personally own the details—from high-level scenario planning to the tactical mechanics of meeting governance and documentation.</div><div><br></div><div><span style="font-size: 18px;"><b>Position Responsibilities: </b></span></div>

Director, Program Management

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Scholar Rock is entering a defining chapter as we prepare to launch our first commercial product. We are seeking a Director of Global Facilities who can lead our facilities function with a strategic, enterprise-wide perspective while remaining deeply engaged in day-to-day operations.&nbsp; This is not a purely administrative role. We need a builder — someone who understands what it takes to scale infrastructure in a growing biotech organization and is equally comfortable shaping long-term facility strategy as they are resolving operational issues in real time.</div><div><br></div><div>With facilities across the globe and ready for future expansion, this leader will ensure our environments are safe, compliant, efficient, and built to support both research and commercial readiness.&nbsp; If you are a self-motivated individual who enjoys the challenges and opportunities that come with a growing, transformative organization, this is an excellent opportunity to apply yourself, learn, and make an impact. You thrive in environments where you are involved in both strategic planning (the bigger picture) and execution. As a catalyst for the organization, you value proactive collaboration, communication, and teamwork as essential for success.&nbsp; &nbsp;&nbsp;</div><div><br></div>

Senior Director of Global Facilities

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>The Director or Senior Director, Regulatory Strategy, reporting to the SVP, Global Head of Regulatory Affairs, is responsible for the development and implementation of the Global Strategy for assigned clinical and/or pipeline programs globally depending on the program. As a subject matter expert, this individual will represent regulatory affairs at the appropriate program team, highlighting risks and opportunities to inform program strategy and plan. The successful candidate will lead interactions with the regulatory authorities, directing the preparation and submission of regulatory submissions and correspondence.</div>

Director/Sr. Director, Regulatory Strategy

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div> <p>We are seeking a strategic, and highly collaborative Vice President &amp; Global Head of Communications to lead our global communications function. The leader will shape and drive all enterprise, executive and business communications strategies and efforts to strengthen our reputation, engage stakeholders, and advance our business and brand across internal and external audiences.<br><br>The ideal candidate will bring a bold communications vision, deep experience and &nbsp;perspective to a diverse range of topics and issues, a track record of influencing and enabling business strategy, and the ability to be agile and lead through complexity, change, and opportunity. This position reports to the Chief Operating Officer and will partner closely with the CEO, the entire executive team and key business leaders to ensure communications are aligned, forward-looking, and aligned with our mission to bring medicine to the communities we serve and become the next great commercial biotech company globally.</p> <p>&nbsp;</p> <p>&nbsp;</p> <h3>Position Responsibilities:&nbsp;</h3> </div>

Vice President, Global Head of Communications

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>Reporting to the SVP, Finance, the Director of Accounting Operations will have responsibility for the Accounting operations function at Scholar Rock. The successful candidate will have a proven track record in managing accounting processes in a public company with a commercial asset. To lead the accounting function, the candidate will be required to have in-depth knowledge of accounting processes and systems including the general ledger, payroll, equity, and T&amp;E systems. &nbsp;The successful candidate will have a working knowledge of consolidations, accounting for clinical trials, cost accounting, transparency reporting, intercompany reconciliations, payroll, and equity, as well as having a strategic focus to ensure the systems and processes are scalable to meet the growing needs of the Company, while still maintaining compliance with internal control requirements.</div> <div>&nbsp;</div> <div>This position will require a hands-on approach, strong organization, clear communication, attention to detail and a great sense of teamwork. This position represents a great opportunity to help build a critical function at a growing and evolving, multi-product candidate biotechnology company.</div>

Director of Accounting Operations

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>We have an exciting opportunity for a qualified European patent attorney to join the Legal Department at Scholar Rock to support all aspects of the company’s global intellectual property portfolio.&nbsp;</div> <div><br>Scholar Rock is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and delivering therapies that create new possibilities for patients suffering from rare neuromuscular diseases. &nbsp;The company is preparing for potential FDA and EMA approval of apitegromab for the treatment of children and adults living with SMA.&nbsp;</div> <div><br>Since its foundation in 2012, Scholar Rock has steadily built an extensive patent portfolio to protect its intellectual property. As a rare disease-focused company, Europe is a key jurisdiction, where strong IP protection can generate value to the company.&nbsp;</div> <div><br>This is a highly visible position where you will build partnerships across the business to drive the IP strategy. The company is seeking a seasoned European patent attorney with extensive experience in EPO opposition practice to work from the company's Zug, Switzerland office.&nbsp;</div> <div><br>You will lead EPO opposition matters and work cross-functionally to provide proactive support, harvest inventions, conduct FTO searches and analyses, from target to launch. Robust scientific curiosity, commitment to excellence, and the ability to do so through effective communication and collaboration are key elements for success for this position. This role reports into the SVP, Head of IP. Prior global patent litigation exposure preferred.</div>

Head of IP, Europe

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div>We are seeking a Contracts Director to lead our contracts processes and negotiations and provide general contracting advice across functional teams, including Development, Research, CMC/Technical Operations, Commercial and IT. &nbsp;This is an outstanding opportunity to join the legal team of a well-funded, growing biotechnology company preparing for its first product commercial launch, after recently receiving positive Phase III data and completing a successful financing. &nbsp;The primary responsibilities of the Contracts Director will be overseeing the contracts process as well as drafting, revising, and negotiating a high volume of time-sensitive agreements. &nbsp;You will be responsible for leading the contracts management function, implementing special projects such as the contracts management system, managing external law firms, and creating, and implementing new processes, trainings, reports, and systems related to managing the company’s agreements. &nbsp;You will be an integral member of a growing legal team where you will have the opportunity to be part of a collaborative team and work with experienced corporate and IP attorneys and compliance experts. &nbsp;This position reports to the Vice President, Corporate Legal and is located in the Cambridge office. &nbsp;The Company has flexibility with hybrid work arrangements.</div>

Contracts Director

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div> <p>The purpose of the internship is to provide real world exposure to FP&amp;A. The ideal candidate will have strong academic achievement, ability to multi-task in a demanding environment, and strong leadership potential.</p> </div>

Financial Planning & Analysis Intern

<div><i>Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. </i></div><div><i>&nbsp;</i></div><div><i>Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at </i><a rel="noopener noreferrer" class="postings-link" href="http://www.scholarrock.com/"><i>ScholarRock.com</i></a><i> and follow </i><a rel="noopener noreferrer" class="postings-link" href="http://www.twitter.com/scholarrock"><i>@ScholarRock</i></a><i> and on </i><a rel="noopener noreferrer" class="postings-link" href="https://www.linkedin.com/company/scholar-rock"><i>LinkedIn</i></a><i>.</i></div><div><br></div><div><b style="font-size: 18px;">Summary of Position:</b></div><div><br></div><div> <p>The MSL/Sr MSL role will represent the real time voice of KOL/HCP input related product development opportunities and scientific exchange on pipeline and commercial products; conduct clinical presentations to payer organizations.&nbsp; The ideal candidate will be a strong leader with a proven ability to leverage their high scientific acumen to engaged and educate on scientifically complex concepts and products. The preferred candidate will also have a proven strategic and innovative style combined with a flexible, hands-on nature that works with a high sense of urgency.</p> </div>

Medical Science Liaison- Great Lakes

Senior Medical Science Liaison, Northeast

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div> <div>&nbsp;</div> <div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div> <p>The Senior Director, Business Analytics will provide strategic leadership for enterprise‑wide analytics supporting Scholar Rock’s commercial launch and long‑term growth. This role is responsible for defining the analytics vision and roadmap across commercial, ensuring data‑driven decision‑making at both the executive and operational levels.</p> <p>The successful candidate will blend strong strategic thinking with hands‑on analytical leadership, deep cross‑functional collaboration, and experience operating in dynamic pre‑ and post‑launch environments. This is a high‑visibility role with direct impact on launch readiness, go‑to‑market execution, and performance management.</p> <p>In addition, this role will identify critical business issues and growth opportunities, partner closely with cross‑functional teams, and embed an external market perspective into the company’s strategic direction.</p> </div>

Senior Director, Business Analytics

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div> <div>&nbsp;</div> <div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div>Scholar Rock is seeking an experienced biopharmaceutical attorney with rare disease product launch experience to serve as VP, Commercial Legal Counsel.&nbsp; The position reports to the General Counsel &amp; Corporate Secretary and is a key partner to the U.S. commercial and medical affairs organization, responsible for providing strategic legal guidance related to Scholar Rock’s planned commercialization activities.&nbsp; <br><br></div>

Vice President, Commercial Legal Counsel

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div> <div>&nbsp;</div> <div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div> <p>The Medical Director, reporting to the VP/SVP, Clinical Research, will be a member of the clinical research team, accountable for driving clinical development activities for assigned product candidates. The successful candidate will be responsible for providing medical leadership for clinical development activities in alignment with corporate strategy. This position requires a highly motivated physician scientist with hands-on expertise in advancing product candidates to deliver life-changing medicines.</p> </div>

Medical Director/Sr Director, Clinical Research

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div> <div>&nbsp;</div> <div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div> <p>Scholar Rock is seeking an experienced and motivated Director of Quality Systems and GxP Compliance. Reporting to the Senior Director, Global Quality Systems and Compliance, this position will oversee aspects of quality systems and regulatory compliance across commercial, clinical, and development activities.</p> </div>

Director, Global Quality Systems and Compliance

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div> <div>&nbsp;</div> <div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div> <p>The Unblinded Clinical Trial Manager is responsible for all unblinded operational aspects of a clinical study from setup through final report, with support from Clinical Operations Leadership. Depending on study scope and complexity, this role may coordinate activities of internal team members (e.g. Clinical Research Associates, Data Managers), and oversee multiple external vendors and consultants as needed. The Unblinded Clinical Trial Manager may also serve as the in-house Unblinded Lead Clinical Research Associate, as needed.</p> </div>

Unblinded Clinical Trial Manager

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div> <div>&nbsp;</div> <div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div> <p>Scholar Rock is seeking an experienced and motivated Director of Vendor Quality Management. Reporting to the Senior Director, Global Quality Systems and Compliance, this position will oversee vendors and service providers that impact GxP activities.</p> </div>

Director, Vendor Quality Management

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div> <div>&nbsp;</div> <div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div> <p>Reporting to the Senior Director, FP&amp;A, the Director of FP&amp;A will support G&amp;A, Global Medical Affairs, and Operations at Scholar Rock. The ideal candidate will have a strong track record of planning and delivering against financial objectives in partnership with cross-functional stakeholders. This person will also serve as a strategic partner, helping frame decisions, evaluate options, and drive value creation. Success in this role requires effective communication, organization, and collaboration skills. It is an excellent opportunity to help build a critical cross-functional capability at a growing biotechnology company with multiple product candidates.</p> </div>

Director, Financial Planning & Analysis

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div> <div>&nbsp;</div> <div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div><span data-contrast="auto">The Human Resource Business Partner (HRBP) provides HR leadership and support to our Research &amp; Development and Tech Ops &amp; Quality organizations. The HRBP is a trusted advisor to leaders, providing expert HR advice and advanced solutions that enable the achievement of business strategies by leveraging effective people processes. This role drives talent, culture, change management and operational excellence for the US &amp; Global organizations, overseeing the delivery of HR programs and services such as leadership, talent acquisition &amp; talent management including employee development, coaching, compensation processes, performance management, organization and change management.&nbsp;&nbsp;This role will also lead Employee Relations processes and procedures to enable effective management, conflict resolution, and problem solving across these organizations. </span><span data-ccp-props="{}">&nbsp;</span></div>

Sr. Director, HR Business Partner (R & D and Tech Ops & Quality)

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div> <div>&nbsp;</div> <div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div><span data-contrast="auto">The Human Resource Business Partner (HRBP) provides HR leadership and support to our US &amp; Global Operations teams. The HRBP is a trusted advisor to leaders, providing expert HR advice and advanced solutions that enable the achievement of business strategies by leveraging effective people processes. This role drives talent, culture, change management and operational excellence for the US &amp; Global organizations, overseeing the delivery of HR programs and services such as leadership, talent acquisition &amp; talent management including employee development, coaching, compensation processes, performance management, organization and change management. &nbsp;This role will also lead Employee Relations processes and procedures to enable effective management, conflict resolution, and problem solving across these organizations. </span><span data-ccp-props="{}">&nbsp;</span></div>

Sr. Director, HR Business Partner (US & Global Operations)

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div>
<div>&nbsp;</div>
<div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div>Scholar Rock is seeking a Director, Next Wave, Program Management to serve as the primary operational partner for the Next Wave Program Team.</div>
<div><br>The Next Wave team is responsible for advancing Scholar Rock’s portfolio of pipeline programs from translation to clinical proof-of concept. This role, reporting to the VP, Head of Program Leadership &amp; Management, will ensure the Next Wave team urgently progresses future innovation with precision, alignment and cross-functional rigor. The position is designed for a high-accountability individual who partners seamlessly with the Program Leader and requires the professional range and horsepower to be the operational anchor for multiple development programs at different stages, while also serving as a strategic thought-partner to the Program Leader.</div>
<div>&nbsp;</div>
<div>&nbsp;</div>
<h3>Position Responsibilities</h3>

Director, Program Management, Next Wave

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div>
<div>&nbsp;</div>
<div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div>
<p>Scholar Rock is seeking an experienced and motivated Senior Director, Commercial Quality / Market Quality (Switzerland) to build and lead a phase-appropriate, scalable, and inspection-ready Commercial Quality function as Scholar Rock advances to and expands in commercial supply. Reporting to the Head of Global Quality, this role is the Quality leader accountable for establishing clear separation between manufacturing control and commercial control through creation of a dedicated Market Release Authorization vertical, ensuring compliant disposition for each market and reliable supply to patients.</p>
<p>Based in Switzerland, the Senior Director, Commercial Quality is accountable for EU/EEA-aligned commercial quality governance, including oversight of QP certification and market release readiness (where applicable), and for establishing the authority to place and lift commercial holds (including for safety, distribution, shortage mitigation, and recall/field action reasons). This leader will create robust post-market controls that meet FDA, European/Swiss expectations (and ROW in market requirements) to ensure compliant product release, complaint handling, investigations/CAPA, and effective management of quality risks in the marketplace.&nbsp;</p>
</div>

Sr. Director, Commercial Quality / Market Quality

<div><em>Scholar Rock is a late-stage <span data-ogsc="red">global&nbsp;</span>biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.&nbsp;Scholar Rock&nbsp;works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at </em><a rel="noopener noreferrer" href="http://www.scholarrock.com/" class="postings-link"><em>ScholarRock.com</em></a><em> and follow </em><a rel="noopener noreferrer" href="http://www.twitter.com/scholarrock" class="postings-link"><em>@ScholarRock</em></a><em> on X and on&nbsp;</em><a rel="noopener noreferrer" href="https://www.linkedin.com/company/scholar-rock" class="postings-link"><em>LinkedIn</em></a><em>.</em></div>
<div>&nbsp;</div>
<div><strong style="font-size: 18px;">Summary of Position:</strong></div><div><br></div><div>
<p style="text-align: justify; margin: 0in; font-size: 12pt; font-family: Cambria, serif;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif;">The Director of Supply Chain is responsible for building, implementing, and managing the commercial supply chain for Scholar Rock in Japan. The role will oversee daily operations relating to artwork, secondary packaging and distribution activities and will work closely with Scholar Rock colleagues globally, primarily in the US and Ireland. </span><span style="font-size: 10.0pt; font-family: Arial, sans-serif;">The position requires strong leadership, problem-solving, and analytical skills to optimize operational efficiency, reduce costs, and ensure products are reliably and compliantly supplied across Japan.</span></p>
</div>

Get a job referral to Scholar Rock Holding

Description

Jobs· 10 open

About

Financials

Referrals

Your career is worth investing in.

Get unlimited referrals with Premium.